Actively Recruiting
Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis
Led by Marmara University · Updated on 2026-04-02
75
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multiple sclerosis (MS) is a chronic neurological disease frequently associated with spasticity, which may lead to functional limitations and reduced quality of life. Although spasticity is common in MS, detailed descriptions of upper and lower extremity spasticity patterns are limited. A better understanding of spasticity patterns may help improve individualized rehabilitation and treatment planning. The aim of this study is to classify upper and lower extremity spasticity patterns in patients with multiple sclerosis and to investigate their association with quality of life. Adult patients with MS and clinical spasticity will be recruited from a tertiary care outpatient clinic. Spasticity will be evaluated using the Modified Ashworth Scale, and extremity postures will be recorded to define spasticity patterns. Functional performance will be assessed using the Timed 25-Foot Walk Test and the 9-Hole Peg Test. The impact of spasticity on quality of life will be evaluated using the Patient-Reported Impact of Spasticity Measure (PRISM). This prospective cross-sectional study is designed to provide a systematic description of spasticity patterns in patients with multiple sclerosis and to examine their relationship with functional outcomes and quality of life.
CONDITIONS
Official Title
Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of multiple sclerosis according to the 2024 McDonald criteria
- Age 18 years or older
- Clinical spasticity with a Modified Ashworth Scale score of 1 or higher in at least one joint
- Ability to understand study procedures and give informed consent
- No significant cognitive impairment
You will not qualify if you...
- Other orthopedic, rheumatologic, or neurological conditions affecting movement besides multiple sclerosis
- Botulinum toxin type A injection within the past 3 months
- Previous surgery for upper extremity spasticity
- Bone deformities affecting the upper extremity
- Unable or unwilling to provide informed consent
- Presence of cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Marmara Üniversitesi Tıp Fakültesi, Istanbul, Maltepe 34854
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
F
Fatma Saika Kahvecioglu Atabay
CONTACT
E
Evrim Karadag Saygi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here